figshare
Browse
13287_2016_467_MOESM4_ESM.pdf (1.34 MB)

Additional file 4: Figure S2. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration

Download (1.34 MB)
journal contribution
posted on 2017-02-10, 05:00 authored by Anna Skorska, Paula Müller, Ralf Gaebel, Jana Große, Heiko Lemcke, Cornelia Lux, Manuela Bastian, Frauke Hausburg, Nicole Zarniko, Sandra Bubritzki, Ulrike Ruch, Gudrun Tiedemann, Robert David, Gustav Steinhoff
Schematic schedule of the CD133+ cell isolation process using the CliniMACS Prodigy® BM-133 system. Gray: manual steps (two operators); green: semi-automatic steps (one operator, dual control); blue: automatic steps. (PDF 1368 kb)

Funding

Federal Ministry of Education and Research Germany

History

Usage metrics

    Stem Cell Research & Therapy

    Categories

    Keywords

    Cardiovascular regenerationAdult hematopoietic stem cellsProdigyGood Manufacturing Practice (GMP)Clinical translationAdvanced therapy medicinal product (ATMP)CD133+ cellsStem cell transplantation

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC